YAVNE, Israel--(BUSINESS WIRE)--
MediWound Ltd. (Nasdaq: MDWD), a fully integrated biopharmaceutical
company bringing innovative therapies to address unmet needs in severe
burn and wound management, today announced that MediWound's management
team will be presenting the Company's corporate overview at the
following investor conferences in November.
The Credit Suisse 2014 Healthcare Conference taking place from
November 10-13, 2014 at The Arizona Biltmore in Phoenix, Arizona. Gal
Cohen, President and Chief Executive Officer of MediWound, will
deliver the corporate presentation on Tuesday, November 11th at 1:30
p.m. local time.
The Jefferies 2014 Global Healthcare Conference taking place from
November 19-20th at the Waldorf Hilton Hotel - Aldwych in London. Mr.
Cohen will deliver the corporate presentation on Wednesday, November
19th at 3:00 p.m. local time.
Live webcasts of both presentations can be accessed by visiting the
investors section of the company's website at www.mediwound.com.
A replay of the webcasts will be archived on the MediWound website for
90 days following each respective presentation.
About MediWound Ltd.
MediWound is a fully integrated biopharmaceutical company focused on
developing, manufacturing and commercializing novel therapeutics based
on its patented proteolytic enzyme technology to address unmet needs in
the fields of severe burns, as well as chronic and other hard-to-heal
wounds. MediWound's first innovative biopharmaceutical product,
NexoBrid, received marketing authorization from the European Medicines
Agency for removal of dead or damaged tissue, known as eschar, in adults
with deep partial- and full-thickness thermal burns and has been
launched in Europe. NexoBrid represents a new paradigm in burn care
management, and clinical trials have demonstrated, with statistical
significance, its ability to non-surgically and rapidly remove the
eschar earlier and, without harming viable tissues. For more
information, please visit www.mediwound.com.
Chief Financial & Operation
Senior Vice President
Source: MediWound Ltd.
News Provided by Acquire Media